Suppr超能文献

相似文献

1
The APOBEC3 family of retroelement restriction factors.
Curr Top Microbiol Immunol. 2013;371:1-27. doi: 10.1007/978-3-642-37765-5_1.
2
Human APOBEC3 Variations and Viral Infection.
Viruses. 2021 Jul 14;13(7):1366. doi: 10.3390/v13071366.
3
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
4
HIV restriction by APOBEC3 in humanized mice.
PLoS Pathog. 2013 Mar;9(3):e1003242. doi: 10.1371/journal.ppat.1003242. Epub 2013 Mar 28.
5
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01224-18. Print 2018 Oct 1.
6
APOBEC3 genes: retroviral restriction factors to cancer drivers.
Trends Mol Med. 2015 May;21(5):274-84. doi: 10.1016/j.molmed.2015.02.007. Epub 2015 Mar 25.
7
HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.
J Virol. 2012 Nov;86(21):11712-24. doi: 10.1128/JVI.00595-12. Epub 2012 Aug 22.
8
Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates.
ACS Infect Dis. 2018 Mar 9;4(3):224-238. doi: 10.1021/acsinfecdis.7b00221. Epub 2018 Feb 9.
9
APOBEC3 proteins and genomic stability: the high cost of a good defense.
Cell Cycle. 2012 Jan 1;11(1):33-8. doi: 10.4161/cc.11.1.18706.
10
Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.
J Leukoc Biol. 2018 Mar;103(3):433-444. doi: 10.1002/JLB.2MR0717-310R. Epub 2017 Dec 15.

引用本文的文献

3
Defining APOBEC-induced mutation signatures and modifying activities in yeast.
Methods Enzymol. 2025;713:115-161. doi: 10.1016/bs.mie.2024.11.041. Epub 2025 Apr 2.
4
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.
Int J Mol Sci. 2025 Feb 12;26(4):1561. doi: 10.3390/ijms26041561.
5
Revealing the hidden RBP-RNA interactions with RNA modification enzyme-based strategies.
Wiley Interdiscip Rev RNA. 2024 May-Jun;15(3):e1863. doi: 10.1002/wrna.1863.
8
Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
PLoS Genet. 2024 May 28;20(5):e1011293. doi: 10.1371/journal.pgen.1011293. eCollection 2024 May.
9
A tale of endurance: bats, viruses and immune dynamics.
Future Microbiol. 2024 Jun 12;19(9):841-856. doi: 10.2217/fmb-2023-0233. Epub 2024 Apr 22.
10
Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered.
J Mol Cell Biol. 2024 Jul 29;16(2). doi: 10.1093/jmcb/mjae005.

本文引用的文献

1
A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3G.
Biology (Basel). 2012 Aug 2;1(2):260-76. doi: 10.3390/biology1020260.
2
APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.
J Mol Biol. 2014 Mar 20;426(6):1296-307. doi: 10.1016/j.jmb.2013.12.014. Epub 2013 Dec 17.
3
Footprint of APOBEC3 on the genome of human retroelements.
J Virol. 2013 Jul;87(14):8195-204. doi: 10.1128/JVI.00298-13. Epub 2013 May 22.
4
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
Structure. 2013 Jun 4;21(6):1042-50. doi: 10.1016/j.str.2013.04.010. Epub 2013 May 16.
5
Indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.
Chem Biol Drug Des. 2013 Jun;81(6):730-41. doi: 10.1111/cbdd.12119.
6
APOBEC3B is an enzymatic source of mutation in breast cancer.
Nature. 2013 Feb 21;494(7437):366-70. doi: 10.1038/nature11881. Epub 2013 Feb 6.
7
Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.
Cell Cycle. 2013 Mar 1;12(5):762-72. doi: 10.4161/cc.23713. Epub 2013 Feb 6.
8
Design, synthesis and biological evaluation of indolizine derivatives as HIV-1 VIF-ElonginC interaction inhibitors.
Mol Divers. 2013 May;17(2):221-43. doi: 10.1007/s11030-013-9424-3. Epub 2013 Feb 3.
9
CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
Mol Cell. 2013 Feb 21;49(4):632-44. doi: 10.1016/j.molcel.2012.12.012. Epub 2013 Jan 17.
10
Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold.
ChemMedChem. 2013 Jan;8(1):112-7. doi: 10.1002/cmdc.201200411. Epub 2012 Nov 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验